Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $681.91 | 13 | 97.8% |
| Education | $15.27 | 1 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $148.05 | 3 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $122.04 | 1 | $0 (2017) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $112.54 | 2 | $0 (2024) |
| Galderma Laboratories, L.P. | $80.63 | 1 | $0 (2019) |
| Almirall LLC | $73.85 | 2 | $0 (2021) |
| Celgene Corporation | $65.10 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $32.53 | 1 | $0 (2017) |
| Amgen Inc. | $30.50 | 1 | $0 (2024) |
| Dermavant Sciences, Inc. | $26.51 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $77.93 | 3 | Amgen Inc. ($30.50) |
| 2023 | $148.05 | 3 | PFIZER INC. ($148.05) |
| 2021 | $16.74 | 1 | Almirall LLC ($16.74) |
| 2019 | $299.89 | 5 | Ortho Dermatologics, a division of Bausch Health US, LLC ($91.62) |
| 2017 | $154.57 | 2 | Regeneron Healthcare Solutions, Inc. ($122.04) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $30.50 | General |
| Category: Inflammation | ||||||
| 05/30/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA, ARAZLO | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Dermatology | ||||||
| 03/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.51 | General |
| Category: DERMATOLOGY | ||||||
| 04/10/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 01/14/2023 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $74.83 | General |
| 01/13/2023 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $57.95 | General |
| Category: Inflammation & Immunology | ||||||
| 06/02/2021 | Almirall LLC | Seysara (Drug) | Food and Beverage | Cash or cash equivalent | $16.74 | General |
| Category: Dermatology | ||||||
| 03/11/2019 | STRATA Skin Sciences, Inc. | Dermatological Psoriasis and Vitiligo Treatment (Device) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: Dermatology | ||||||
| 01/21/2019 | Celgene Corporation | Otezla (Drug) | Food and Beverage | Cash or cash equivalent | $65.10 | General |
| Category: Dermatology | ||||||
| 01/19/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $91.62 | General |
| Category: DERMATOLOGY | ||||||
| 01/19/2019 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $80.63 | General |
| 01/04/2019 | Almirall LLC | — | Food and Beverage | Cash or cash equivalent | $57.11 | General |
| 11/09/2017 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $122.04 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/23/2017 | Janssen Biotech, Inc. | GUSELKUMAB (Biological) | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: R&D Compound | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,874 | 3,895 | $683,958 | $207,922 |
| 2022 | 12 | 1,832 | 4,041 | $656,359 | $200,160 |
| 2021 | 16 | 1,844 | 4,136 | $651,338 | $209,448 |
| 2020 | 11 | 1,390 | 2,832 | $420,788 | $118,943 |
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 555 | 816 | $201,552 | $61,173 | 30.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 250 | 325 | $118,300 | $35,497 | 30.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 183 | 216 | $60,562 | $24,227 | 40.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 297 | 412 | $86,485 | $23,189 | 26.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 93 | 130 | $67,210 | $21,680 | 32.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 119 | 131 | $46,500 | $13,020 | 28.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 237 | 1,719 | $36,099 | $12,291 | 34.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 22 | 22 | $29,133 | $6,691 | 23.0% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 29 | 29 | $13,021 | $3,850 | 29.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 51 | 54 | $8,316 | $2,880 | 34.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $6,348 | $1,532 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $6,094 | $1,019 | 16.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 15 | 18 | $4,338 | $871.71 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 550 | 841 | $201,840 | $60,717 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 237 | 295 | $104,135 | $31,137 | 29.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 119 | 163 | $82,641 | $27,624 | 33.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 301 | 392 | $82,560 | $20,880 | 25.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 156 | 183 | $48,374 | $19,683 | 40.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 261 | 1,946 | $40,866 | $13,696 | 33.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 117 | 127 | $42,360 | $12,662 | 29.9% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 22 | 22 | $28,552 | $6,837 | 23.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 22 | 23 | $9,798 | $2,897 | 29.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 15 | 15 | $7,523 | $1,906 | 25.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $4,602 | $1,167 | 25.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 19 | 21 | $3,108 | $953.39 | 30.7% |
About Dr. Amy Adams, M.D
Dr. Amy Adams, M.D is a Dermatology healthcare provider based in Palo Alto, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679643928.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amy Adams, M.D has received a total of $697.18 in payments from pharmaceutical and medical device companies, with $77.93 received in 2024. These payments were reported across 14 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($681.91).
As a Medicare-enrolled provider, Adams has provided services to 6,940 Medicare beneficiaries, totaling 14,904 services with total Medicare billing of $736,472. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Palo Alto, CA
- Active Since 11/08/2006
- Last Updated 07/15/2020
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1679643928
Products in Payments
- DUPIXENT DUPILUMAB INJECTION (Biological) $122.04
- Otezla (Drug) $95.60
- SILIQ (Drug) $91.62
- CIBINQO (Drug) $73.22
- GUSELKUMAB (Biological) $32.53
- VTAMA (Drug) $26.51
- Cabtreo (Drug) $20.92
- Seysara (Drug) $16.74
- Dermatological Psoriasis and Vitiligo Treatment (Device) $5.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Palo Alto
John Doux, M.d, M.D
Dermatology — Payments: $124,944
Joyce Teng, Md, MD
Dermatology — Payments: $115,109
Shireen Guide, Md, MD
Dermatology — Payments: $79,371
Ilka Netravali, Md, MD
Dermatology — Payments: $28,025
Dr. Daniel Navi, M.d, M.D
Dermatology — Payments: $19,065
Dr. Thomas Hoffman, M.d, M.D
Dermatology — Payments: $17,860